Beam Therapeutics’ experimental gene-editing therapy for sickle cell disease now has its first cut of patient data showing signs of treating the rare blood disorder in a way that could differentiate ...

CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (BEAM) (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

Step onto any household or commercial weighing scale, and suddenly your weight magically appears in neat digital numbers. But how does a simple platform know exactly how much you weigh down to a tenth ...

Beam Therapeutics (NASDAQ:BEAM) shared promising results from the early stage trial of its genetically modified cell therapy, BEAM-101, for the treatment of severe sickle cell disease. The data ...

The LCL Series thin-beam load cells are designed to measure force or weight. An integrated strain gage includes four active-arm full-bridge, all-balancing compensating and conductive elements.